google-site-verification: googlec7193c3de77668c9.html

Triple pre-surgery therapy may boost immunity against soft tissue sarcoma

[
Early results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center and Stanford Medicine suggest that combining targeted radiation therapy with an experimental immune-boosting drug called BO-112 and anti-PD-1 therapy before surgery may help the immune system fight aggressive soft tissue sarcomas.


Source link

Advertisements
Views: 1

See also  The most effective migraine drugs should be promoted globally and guidelines updated accordingly, say researchers

Check Also

Ebola.jpg

No vaccine for latest Ebola outbreak, DRC warns as toll hits 80

[ Credit: Unsplash/CC0 Public Domain An Ebola outbreak in the Democratic Republic of Congo that …

Muscle mass is preserved after obesity drug treatment, study suggests

[ Credit: Unsplash/CC0 Public Domain New research presented at the European Congress on Obesity (ECO2026) …

New AI tool could replace costly cancer gene expression profiling

[ Credit: Cell (2026). DOI: 10.1016/j.cell.2026.04.023 A team led by Cedars-Sinai Health Sciences University investigators …

Leave a Reply

Available for Amazon Prime